- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : 프루퀸티닙과 캄렐리주맙의 병용
총 146979 건
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Jiangxi Provincial Cancer Hospital; Shenzhen People... 그리고 다른 협력자들모병
-
Nanfang Hospital of Southern Medical University모병
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.모병
-
Chinese PLA General Hospital모병
-
Shanghai Pulmonary Hospital, Shanghai, China모집하지 않고 적극적으로
-
Jiangsu HengRui Medicine Co., Ltd.모집하지 않고 적극적으로
-
China Medical University, China모병
-
Sheba Medical Center모집하지 않고 적극적으로
-
Guangzhou University of Traditional Chinese Medicine아직 모집하지 않음
-
Guangxi Medical UniversityJiangsu HengRui Medicine Co., Ltd.모병
-
NEOS SurgeryHospital Clinic of Barcelona; Complejo Hospitalario de Navarra; Universitätsklinikum Freiburg모병
-
Sun Yat-sen University모병
-
Beijing Tsinghua Chang Gung Hospital알려지지 않은
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University모병화학 요법 효과 | BCLC C기 간세포 암종중국
-
Sichuan University아직 모집하지 않음TACE와 결합된 Carrelizumab + Lenvatinib | 경계선 절제 가능한 간세포 암종중국
-
Jiangsu HengRui Medicine Co., Ltd.종료됨
-
Sun Yat-sen UniversityWuzhou Red Cross Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Affiliated... 그리고 다른 협력자들모병
-
The First Affiliated Hospital of Soochow UniversityJiangsu HengRui Medicine Co., Ltd.모병
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University모병
-
Hunan Cancer HospitalJiangsu Hengrui Pharmaceuticals Co.,Ltd모병
-
Peking University First Hospital아직 모집하지 않음
-
Zhejiang UniversityHuashan Hospital; West China Hospital; The First Affiliated Hospital of Zhengzhou University 그리고 다른 협력자들알려지지 않은
-
Raymond T. Chung, MDMerck Sharp & Dohme LLC빼는
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.모집하지 않고 적극적으로
-
PharmaKing완전한
-
Nanfang Hospital of Southern Medical University모병
-
The First Affiliated Hospital of Xiamen University아직 모집하지 않음
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University아직 모집하지 않음
-
Alzheimer's Light LLC모병
-
Yonsei University모병
-
The First Affiliated Hospital with Nanjing Medical...모병
-
Université de LubumbashiCenters for Disease Control and Prevention; Universiteit Antwerpen알려지지 않은
-
Zhejiang Cancer Hospital아직 모집하지 않음위암, HIPEC, Anti-PD-1 항체 Camrelizumab(SHR-1210), 화학요법 및 수술중국
-
Fudan University아직 모집하지 않음